Project Grant R21MH135589
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$207K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institute of Mental Health (NIMH) awarded a $162,000 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the Research Foundation For Mental Hygiene, Inc. (RFMH), doing business as the New York Psychiatric Center. The project, titled "Transcriptional Diversity of Human Mediodorsal Thalamus and Its Role in Psychiatric Disease", will investigate the transcriptional signatures and genetic factors underlying differences in thalamocortical connectivity...
The National Institute of Mental Health (NIMH) awarded a $157,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of California, Irvine. The grant supports research to determine the impact of dopamine receptor 2 (D2R) signaling in astrocytes on prefrontal cortex functions. Specifically, the project aims to use viral vectors to knockdown D2R in astrocytes of mice with normal or altered dopamine synthesis/release, in order to elucidate the role of astrocytic D2R...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $2,181,744 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to study how mutations in the NRXN1 gene impact striatal neuromodulatory signals and goal-directed behavior. The research aims to mechanistically investigate how NRXN1 functions within midbrain dopamine neurons...
This $459,613 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program aims to investigate modulating endogenous opioid signaling as a potential treatment for deficits in reward processing associated with psychiatric disorders. The project will administer a drug that inhibits the degradation of endogenous enkephalins to chronically stressed mice and record neural activity in reward-related brain regions as the mice...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $396,250 to Vanderbilt University to conduct research on the regulation of metabotropic glutamate receptor activity by protein/protein interactions. The 5-year project, starting on December 1, 2024, aims to: Test a suite of control agonists, positive allosteric modulators (PAMs), and negative allosteric modulators (NAMs) for activity at mGlu7...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), will fund research at the University of Colorado-Denver to investigate the role of synaptic adhesion molecules in guiding myelination of specific axons. The $429,000 grant, awarded from June 2025 to May 2027, will support the development of novel tools to visualize gene expression and protein localization related to axon-myelin interactions in living...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is funding research at the University of Colorado-Denver to investigate the mechanisms by which inhibitory GABAergic synapses heterosynaptically regulate excitatory glutamatergic synapses during brain development and plasticity. The $429,000 grant, awarded on August 1, 2024, will support the use of advanced optical techniques to address two key questions:...
The National Institute of Mental Health (NIMH) awarded a 3-year, $413,681 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the University of Dayton Research Institute to study the role of phospholamban (PLN), a critical calcium regulatory protein, in the thalamic reticular nucleus (TRN) of the brain. The research aims to decipher the cellular and molecular mechanisms by which PLN regulates the signaling properties of TRN neurons and influences behavioral outcomes like locomotor...
The National Institute of Mental Health (NIMH) awarded a $1,854,632 Project Grant under CFDA 93.242 (Mental Health Research Grants) to The Children's Hospital of Philadelphia Research Institute. The purpose of this 5-year grant, awarded on July 19, 2024, is to study the relationship between mitochondrial function, synaptic transmission, and the development of schizophrenia. The research will utilize induced pluripotent stem cell-derived neurons to investigate mitochondrial biogenesis, mitophagy,...
This Project Grant award from the National Institute of Mental Health (NIMH), under CFDA Program 93.242 "Mental Health Research Grants", is providing $475,388 to The Broad Institute, Inc. to conduct research characterizing the transcriptional and neuro-immune consequences of loss of the high-confidence bipolar disorder risk gene KDM5B. The project aims to investigate the impact of stress on behavior and gene transcription in wild-type and KDM5B heterozygous mice, as well as...